23.1 C
New Delhi
Saturday, November 22, 2025

CIPLA LIMITED APPOINTS ACHIN GUPTA AS MD & GLOBAL CEO

Achin Gupta appointed MD & Global CEO of Cipla Limited, effective April 1, 2026. With over 20 years of experience, he has driven Cipla’s growth and transformation. As current Global COO, he oversees a $3 billion portfolio, driving operational excellence and innovation. Expected to accelerate Cipla’s mission to make healthcare more accessible and affordable.

Cipla Limited, a leading global pharmaceutical company, has announced the appointment of Achin Gupta as its Managing Director & Global Chief Executive Officer (MD & GCEO), effective April 1, 2026. This strategic move marks a significant milestone in Cipla’s leadership evolution, underscoring the company’s commitment to strengthening its global leadership and advancing its mission of providing accessible, high-quality, and innovative healthcare solutions worldwide.

Achin, a seasoned healthcare professional with over two decades of experience, has played a central role in driving Cipla’s growth and transformation. As the current Global Chief Operating Officer, he has overseen a global commercial portfolio exceeding USD 3 billion, steering initiatives that deliver operational excellence, digital transformation, and patient-centric innovation. His leadership has been instrumental in accelerating revenue growth, enhancing market share, and fostering a culture of agility and performance.

Prior to joining Cipla, Achin held leadership roles at Glenmark Pharmaceuticals, where he spearheaded business expansion across Europe, LATAM, the Middle East, and the Asia-Pacific region, transforming the company into a diversified branded and OTC business. His earlier career at Abbott Laboratories provided a strong foundation in global business strategy and operational excellence.

Cipla’s Board of Directors is confident that Achin’s leadership will further strengthen the company’s position as a global healthcare leader, driving growth, innovation, and patient-centric solutions. His appointment is expected to accelerate Cipla’s mission to make healthcare more accessible and affordable, while delivering sustainable value to stakeholders.

spot_img

Must Read

- Advertisement -spot_img

Archives

Related news

- Advertisement -spot_imgspot_img